Page last updated on April 11, 2024
Cocrystal Pharma, Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-03-28 08:01:04 EDT.
Filings
10-K filed on 2024-03-28
Cocrystal Pharma, Inc. filed an 10-K at 2024-03-28 08:01:04 EDT
Accession Number: 0001493152-24-011613
Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!
Item 1C. Cybersecurity.
Item 1C. Cybersecurity Like all companies that utilize technology, we are subject to threats of breaches of our technology systems. To mitigate the threat to our business, we take a comprehensive approach to cybersecurity risk management. Our Board and our management actively oversee our risk management program, including the management of cybersecurity risks. We have established policies, standards, processes and practices for assessing, identifying, and managing material risks from cybersecurity threats, including those discussed in our Risk Factors. We have devoted financial and personnel resources to implement and maintain security measures to meet regulatory requirements and shareholder expectations, and we intend to continue to make investments to maintain the security of our data and cybersecurity infrastructure. While there can be no guarantee that our policies and procedures will be properly followed in every instance or that those policies and procedures will be effective, we believe that the Company s sustained investment in people and technologies have contributed to a culture of continuous improvement that has put the Company in a position to protect against potential compromises, and we do not believe that risks from prior cybersecurity threats have materially affected our business to date. We can provide no assurance that there will not be incidents in the future or that past or future attacks will not materially affect us, including our business strategy, results of operations, or financial condition. 40
Company Information
| Name | Cocrystal Pharma, Inc. |
| CIK | 0001412486 |
| SIC Description | Pharmaceutical Preparations |
| Ticker | COCP - Nasdaq |
| Website | |
| Category | Non-accelerated filer Smaller reporting company |
| Fiscal Year End | December 30 |